Thiago André Carniel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thiago André Carniel has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Alberto Fancello
GRANTE - Department of Mechanical Engineering, Federal University of Santa Catarina, Florianópolis, Brazil
9 shared publications - Bruno Klahr
GRANTE - Department of Mechanical Engineering, Federal University of Santa Catarina, Florianópolis, SC, Brazil
6 shared publications - Clodoaldo Antônio De Sá
Graduate Program in Health Sciences, Community University of Chapecó Region, Chapecó, SC, Brazil
4 shared publications Eduardo Alberto Fancello
Department of Mechanical Engineering, Federal University of Santa Catarina, Florianópolis, SC, Brazil; University Hospital, Federal University of Santa Catarina, Florianópolis, SC, Brazil
4 shared publications- José Luís Medeiros Thiesen
GRANTE ‐ Mechanical and Analysis Design Group, Department of Mechanical Engineering Federal University of Santa Catarina (UFSC) Florianópolis SC Brazil
4 shared publications - Junir Antônio Lutinski
Universidade Comunitária da Região de Chapecó - Unochapecó
4 shared publications
Latest Publications
- Open Access
Forecasting global progress towards the United Nations hypertension control target for 2030
In 2025, the United Nations General Assembly adopted a target of 150 million additional people with hypertension under control by 2030, but did not specify the baseline year. We quantified how baseline choice affects estimated progress towards this target and forecast the number of adults with controlled hypertension globally through 2030. Age- and sex-specific hypertension prevalence and control estimates from the NCD Risk Factor Collaboration for 1990–2019 were combined with United Nations World Population Prospects 2024 for adults aged 30–79 years in 200 countries and territories. Bayesian state-space models generated separate prevalence and control forecasts, propagated through 100 000 posterior draws. We evaluated baselines of 2020, 2023, 2024 and 2025 and decomposed the 2024–2030 change using continuous-change decomposition. Holding the 2030 forecast constant, estimated target attainment ranged from 94.4% with a 2020 baseline to 51.4% with a 2025 baseline. Using the prespecified 2024 baseline, the number of adults with controlled hypertension was forecast to increase from 332.4 million in 2024 to 423.9 million in 2030, an increase of 91.5 million (95% uncertainty interval 75.2–110.0 million), corresponding to 61.0% (95% uncertainty interval 50.2–73.3%) of the target and a median shortfall of 58.5 million. The control-rate improvement component accounted for 66.3% of the increase and demographic change for 44.0%, while declining age–sex-specific hypertension prevalence offset 10.4%. Progress towards this absolute target cannot be interpreted unambiguously without an explicit baseline year. From a 2024 baseline, current forecast trajectories fall short of the 2030 target.
Open AccessForecasting global progress towards the United Nations hypertension control target for 2030
In 2025, the United Nations General Assembly adopted a target of 150 million additional people with hypertension under control by 2030, but did not specify the baseline year. We quantified how baseline choice affects estimated progress towards this target and forecast the number of adults with controlled hypertension globally through 2030. Age- and sex-specific hypertension prevalence and control estimates from the NCD Risk Factor Collaboration for 1990–2019 were combined with United Nations World Population Prospects 2024 for adults aged 30–79 years in 200 countries and territories. Bayesian state-space models generated separate prevalence and control forecasts, propagated through 100 000 posterior draws. We evaluated baselines of 2020, 2023, 2024 and 2025 and decomposed the 2024–2030 change using continuous-change decomposition. Holding the 2030 forecast constant, estimated target attainment ranged from 94.4% with a 2020 baseline to 51.4% with a 2025 baseline. Using the prespecified 2024 baseline, the number of adults with controlled hypertension was forecast to increase from 332.4 million in 2024 to 423.9 million in 2030, an increase of 91.5 million (95% uncertainty interval 75.2–110.0 million), corresponding to 61.0% (95% uncertainty interval 50.2–73.3%) of the target and a median shortfall of 58.5 million. The control-rate improvement component accounted for 66.3% of the increase and demographic change for 44.0%, while declining age–sex-specific hypertension prevalence offset 10.4%. Progress towards this absolute target cannot be interpreted unambiguously without an explicit baseline year. From a 2024 baseline, current forecast trajectories fall short of the 2030 target.
- Open Access
- 25 June 2026
- Published by Universidade Federal de Santa Maria in Geografia Ensino & Pesquisa
- Vol. 30, e93828
Dengue em Santa Catarina: perspectivas diante de um cenário complexo
A dengue tem se apresentada como um dos principais desafios no contexto da saúde pública no Brasil e no mundo. A ocorrência da doença é determinada por múltiplos fatores e a sua incidência e mortalidade têm aumentado especialmente em regiões em que outrora não ocorria, a exemplo do estado de Santa Catarina. O objetivo deste estudo foi avaliar a distribuição espaço temporal e os determinantes sociais de saúde associados à ocorrência de dengue no estado de Santa Catarina no período de 2022 até maio 2024. Trata-se de um estudo epidemiológico retrospectivo e de caráter exploratório baseado em dados secundários do IBGE e do Ministério da Saúde (DataSus). Apresenta uma análise da distribuição da dengue em Santa Catarina, a partir de indicadores dos 295 municípios do estado catarinense com enfoque na incidência, perfil clínico e diagnóstico da doença. A dengue está se tornando endêmica no estado, com aumento das taxas de incidência, internações médias e óbitos, afetando principalmente indivíduos na faixa etária de 20-59 anos, sorotipo prevalente DENV1, PIB e IDHM mostraram-se positivamente associados à incidência da dengue, enquanto o esgotamento sanitário e a área territorial apresentaram associação negativa. Verificou-se maior incidência da doença nos meses que compreendem o primeiro semestre, apresentando um padrão sazonal de ocorrência. Este trabalho é de particular interesse para gestores de saúde, profissionais da área e demais pesquisadores, contribuindo para o aprimoramento das práticas de manejo e controle da dengue.
- 25 June 2026
- Published by Universidade Federal de Santa Maria in Geografia Ensino & Pesquisa
- Vol. 30, e93828
Open AccessDengue em Santa Catarina: perspectivas diante de um cenário complexo
A dengue tem se apresentada como um dos principais desafios no contexto da saúde pública no Brasil e no mundo. A ocorrência da doença é determinada por múltiplos fatores e a sua incidência e mortalidade têm aumentado especialmente em regiões em que outrora não ocorria, a exemplo do estado de Santa Catarina. O objetivo deste estudo foi avaliar a distribuição espaço temporal e os determinantes sociais de saúde associados à ocorrência de dengue no estado de Santa Catarina no período de 2022 até maio 2024. Trata-se de um estudo epidemiológico retrospectivo e de caráter exploratório baseado em dados secundários do IBGE e do Ministério da Saúde (DataSus). Apresenta uma análise da distribuição da dengue em Santa Catarina, a partir de indicadores dos 295 municípios do estado catarinense com enfoque na incidência, perfil clínico e diagnóstico da doença. A dengue está se tornando endêmica no estado, com aumento das taxas de incidência, internações médias e óbitos, afetando principalmente indivíduos na faixa etária de 20-59 anos, sorotipo prevalente DENV1, PIB e IDHM mostraram-se positivamente associados à incidência da dengue, enquanto o esgotamento sanitário e a área territorial apresentaram associação negativa. Verificou-se maior incidência da doença nos meses que compreendem o primeiro semestre, apresentando um padrão sazonal de ocorrência. Este trabalho é de particular interesse para gestores de saúde, profissionais da área e demais pesquisadores, contribuindo para o aprimoramento das práticas de manejo e controle da dengue.
- Open Access
- 30 January 2026
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 35 (2) , e70307
Association Between Polypharmacy and Socioeconomic and Demographic Factors in Adults Aged 50 Years and Older by Brazilian Macroregions
Purpose: This study aimed to investigate the proportions of polypharmacy in the macroregions of Brazil, considering socioeconomic and demographic factors and their associations. Methods: A cross‐sectional analysis was conducted using data from the second wave (2019–2021) of ELSI‐Brazil. The outcome was self‐reported polypharmacy. Independent variables included sociodemographic, health, and behavioral factors, such as diabetes and hypertension. Descriptive analyses incorporated sample weights, and Poisson regression was employed to assess associations between polypharmacy and the independent variables. Analyses were stratified by the five macroregions of Brazil: North, Northeast, Southeast, South, and Central‐West. Results: The study included 6917 participants aged 50 years or older. Differences in polypharmacy prevalence were observed across Brazilian macroregions. In the Central‐West, polypharmacy was less frequent among rural residents (PR = 0.84; 95% CI: 0.82–0.85) than among urban residents. In the North, polypharmacy was more frequent among non‐white individuals (PR = 1.08; 95% CI: 1.02–1.15) and less frequent among Black individuals (PR = 0.92; 95% CI: 0.88–0.96) compared with white individuals. In the Southeast and South, polypharmacy was more frequent among adults aged 80 years or older (PR = 1.14; 95% CI: 1.08–1.19 and PR = 1.17; 95% CI: 1.08–1.27, respectively) than among younger groups. Although no formal statistical comparisons between regions were performed, the observed estimates and their confidence intervals indicate regional variation in polypharmacy. Conclusion: This study identified regional disparities in polypharmacy prevalence across Brazil's macroregions, influenced by factors such as age, chronic conditions, and socioeconomic status. Strengthening primary care, promoting rational medication use, addressing inequalities, and integrating prevention strategies are crucial to mitigating its negative impacts.
- 30 January 2026
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 35 (2) , e70307
Open AccessAssociation Between Polypharmacy and Socioeconomic and Demographic Factors in Adults Aged 50 Years and Older by Brazilian Macroregions
Purpose: This study aimed to investigate the proportions of polypharmacy in the macroregions of Brazil, considering socioeconomic and demographic factors and their associations. Methods: A cross‐sectional analysis was conducted using data from the second wave (2019–2021) of ELSI‐Brazil. The outcome was self‐reported polypharmacy. Independent variables included sociodemographic, health, and behavioral factors, such as diabetes and hypertension. Descriptive analyses incorporated sample weights, and Poisson regression was employed to assess associations between polypharmacy and the independent variables. Analyses were stratified by the five macroregions of Brazil: North, Northeast, Southeast, South, and Central‐West. Results: The study included 6917 participants aged 50 years or older. Differences in polypharmacy prevalence were observed across Brazilian macroregions. In the Central‐West, polypharmacy was less frequent among rural residents (PR = 0.84; 95% CI: 0.82–0.85) than among urban residents. In the North, polypharmacy was more frequent among non‐white individuals (PR = 1.08; 95% CI: 1.02–1.15) and less frequent among Black individuals (PR = 0.92; 95% CI: 0.88–0.96) compared with white individuals. In the Southeast and South, polypharmacy was more frequent among adults aged 80 years or older (PR = 1.14; 95% CI: 1.08–1.19 and PR = 1.17; 95% CI: 1.08–1.27, respectively) than among younger groups. Although no formal statistical comparisons between regions were performed, the observed estimates and their confidence intervals indicate regional variation in polypharmacy. Conclusion: This study identified regional disparities in polypharmacy prevalence across Brazil's macroregions, influenced by factors such as age, chronic conditions, and socioeconomic status. Strengthening primary care, promoting rational medication use, addressing inequalities, and integrating prevention strategies are crucial to mitigating its negative impacts.
- Open Access
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (4)
Impacto do Envelhecimento Populacional na Prevalência de Doenças Cardiovasculares nas Macrorregiões do Brasil: Previsões para 2050
Resumo As doenças cardiovasculares (DCV) têm sido consistentemente a principal causa de morbidade e mortalidade em todo o mundo, com um aumento significativo impulsionado pelo envelhecimento demográfico. Embora o Brasil reflita esse padrão global, esse ônus pode estar distribuído de forma desigual entre suas macrorregiões. O principal objetivo deste trabalho é investigar as tendências de prevalência de DCV nas macrorregiões do Brasil de 1990 a 2021 e prever cenários até 2050, considerando o envelhecimento demográfico. As taxas de prevalência bruta e padronizada por idade foram obtidas do estudo Global Burden of Disease. Modelos neurais de espaço de estados foram utilizados para prever as tendências até 2050, com intervalos de confiança de 95% estimados por meio de uma abordagem semelhante à de Monte Carlo. As taxas de prevalência bruta tendem a aumentar substancialmente em todas as macrorregiões até 2050, com a região Centro-Oeste apresentando o maior aumento (64,6% [52,3-79,5]) e a região Nordeste o menor (39,2% [33,4-46,5]). Em contrapartida, se espera que as taxas padronizadas por idade permaneçam praticamente constantes ao longo dos anos, com apenas um modesto aumento observado no Nordeste (<7%). Mesmo com taxas padronizadas por idade relativamente constantes, se prevê que os sistemas de saúde enfrentem crescentes desafios clínicos e econômicos associados a uma população mais idosa e com maior número de comorbidades. As disparidades regionais reforçam a necessidade de estratégias de prevenção específicas para mitigar o impacto das DCV no Brasil.
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (4)
Open AccessImpacto do Envelhecimento Populacional na Prevalência de Doenças Cardiovasculares nas Macrorregiões do Brasil: Previsões para 2050
Resumo As doenças cardiovasculares (DCV) têm sido consistentemente a principal causa de morbidade e mortalidade em todo o mundo, com um aumento significativo impulsionado pelo envelhecimento demográfico. Embora o Brasil reflita esse padrão global, esse ônus pode estar distribuído de forma desigual entre suas macrorregiões. O principal objetivo deste trabalho é investigar as tendências de prevalência de DCV nas macrorregiões do Brasil de 1990 a 2021 e prever cenários até 2050, considerando o envelhecimento demográfico. As taxas de prevalência bruta e padronizada por idade foram obtidas do estudo Global Burden of Disease. Modelos neurais de espaço de estados foram utilizados para prever as tendências até 2050, com intervalos de confiança de 95% estimados por meio de uma abordagem semelhante à de Monte Carlo. As taxas de prevalência bruta tendem a aumentar substancialmente em todas as macrorregiões até 2050, com a região Centro-Oeste apresentando o maior aumento (64,6% [52,3-79,5]) e a região Nordeste o menor (39,2% [33,4-46,5]). Em contrapartida, se espera que as taxas padronizadas por idade permaneçam praticamente constantes ao longo dos anos, com apenas um modesto aumento observado no Nordeste (<7%). Mesmo com taxas padronizadas por idade relativamente constantes, se prevê que os sistemas de saúde enfrentem crescentes desafios clínicos e econômicos associados a uma população mais idosa e com maior número de comorbidades. As disparidades regionais reforçam a necessidade de estratégias de prevenção específicas para mitigar o impacto das DCV no Brasil.
- Open Access
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (4)
Impact of Population Aging on Cardiovascular Disease Prevalence in the Macroregions of Brazil: Forecasts to 2050
Cardiovascular diseases (CVD) have consistently been the leading cause of morbidity and mortality worldwide, with an increasing burden driven by demographic aging. Although Brazil mirrors this global pattern, this burden may be unevenly distributed across its macroregions. The main objective of this work is to investigate the trends in CVD prevalence in the macroregions of Brazil from 1990 to 2021 and to forecast scenarios to 2050, considering demographic aging. Crude and age-standardized prevalence rates were obtained from the Global Burden of Disease study. Neural state-space models were used to forecast trends to 2050, with 95% confidence intervals estimated via a Monte Carlo-like approach. Crude prevalence rates tend to rise substantially across all macroregions until 2050, with the central-west expected to see the highest rise (64.6% [52.3-79.5]) and the northeast the lowest (39.2% [33.4-46.5]). In contrast, age-standardized rates are expected to remain largely constant across the years, with only a modest increase observed in the northeast (<7%). Even under relatively constant age-standardized rates, health systems are expected to face growing clinical and economic challenges associated with an older and more multimorbid population. Regional disparities underscore the need for tailored prevention strategies to mitigate the burden of CVD in Brazil.
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (4)
Open AccessImpact of Population Aging on Cardiovascular Disease Prevalence in the Macroregions of Brazil: Forecasts to 2050
Cardiovascular diseases (CVD) have consistently been the leading cause of morbidity and mortality worldwide, with an increasing burden driven by demographic aging. Although Brazil mirrors this global pattern, this burden may be unevenly distributed across its macroregions. The main objective of this work is to investigate the trends in CVD prevalence in the macroregions of Brazil from 1990 to 2021 and to forecast scenarios to 2050, considering demographic aging. Crude and age-standardized prevalence rates were obtained from the Global Burden of Disease study. Neural state-space models were used to forecast trends to 2050, with 95% confidence intervals estimated via a Monte Carlo-like approach. Crude prevalence rates tend to rise substantially across all macroregions until 2050, with the central-west expected to see the highest rise (64.6% [52.3-79.5]) and the northeast the lowest (39.2% [33.4-46.5]). In contrast, age-standardized rates are expected to remain largely constant across the years, with only a modest increase observed in the northeast (<7%). Even under relatively constant age-standardized rates, health systems are expected to face growing clinical and economic challenges associated with an older and more multimorbid population. Regional disparities underscore the need for tailored prevention strategies to mitigate the burden of CVD in Brazil.
- Open Access
- 24 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 44462
Assessment of gait speed in older adults using a short–distance walking test with smartphone motion sensors and machine learning
Classical gait speed tests rely on the existence of a flat surface of 4 to 15 meters, distance that is not always available in clinical settings. To address this space constraint and to preserve the well–reported clinical outcomes associated with the gait speed test, the present work investigates the potential of a set of machine learning models to predict the gait speed in older adults, but by means of a short–distance test. To enhance screening, the present framework adopts a risk–stratification model, categorizing gait speed into four strata rather than treating it as a continuous variable. Motion data were obtained with a smartphone from over two hundred older adults. Feature extraction consisted of time– and frequency–domain quantities derived from the acceleration and angular velocity signals based on the discrete wavelet transform and power spectral density. Feature selection was investigated by the ReliefF algorithm. Among the several model setups evaluated, the k–Nearest Neighbors classifier is the one that provided the best predictions (median [95% CI] – accuracy: 0.969 [0.963–0.974]; F1-score: 0.971 [0.964–0.975]; AUC: 0.980 [0.975–0.984]). Based on these figures, the proposed strategy is a promising approach to provide clinicians with a reliable and straightforward gait speed stratification in cases where the classical test is not feasible due to space constraints.
- 24 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 44462
Open AccessAssessment of gait speed in older adults using a short–distance walking test with smartphone motion sensors and machine learning
Classical gait speed tests rely on the existence of a flat surface of 4 to 15 meters, distance that is not always available in clinical settings. To address this space constraint and to preserve the well–reported clinical outcomes associated with the gait speed test, the present work investigates the potential of a set of machine learning models to predict the gait speed in older adults, but by means of a short–distance test. To enhance screening, the present framework adopts a risk–stratification model, categorizing gait speed into four strata rather than treating it as a continuous variable. Motion data were obtained with a smartphone from over two hundred older adults. Feature extraction consisted of time– and frequency–domain quantities derived from the acceleration and angular velocity signals based on the discrete wavelet transform and power spectral density. Feature selection was investigated by the ReliefF algorithm. Among the several model setups evaluated, the k–Nearest Neighbors classifier is the one that provided the best predictions (median [95% CI] – accuracy: 0.969 [0.963–0.974]; F1-score: 0.971 [0.964–0.975]; AUC: 0.980 [0.975–0.984]). Based on these figures, the proposed strategy is a promising approach to provide clinicians with a reliable and straightforward gait speed stratification in cases where the classical test is not feasible due to space constraints.
- Open Access
- 2 October 2025
- Published by Portal de Periódicos UFU - Universidade Federal de Uberlandia in Hygeia - Revista Brasileira de Geografia Médica e da Saúde
- Vol. 21, e2161
RASTREAMENTO DOS CÂNCERES DE MAMA E COLO DE ÚTERO EM MULHERES IDOSAS: ESTUDO DE SÉRIES TEMPORAIS
The study aims to analyze the temporal evolution of breast and cervical cancer screening coverage in elderly women in Brazil. This is an ecological time-series study, between 2014 and 2022, in Brazilian women aged ≥ 60 years. Adherence to screening was assessed by accessing the requests available in the Cancer Information System. The temporal evolution analyses were performed by dividing the number of requests among women aged over 60 years by the female population in the same age group, multiplying the result by one thousand for each year of the series. The Prais-Winsten linear regression model was applied to analyze the temporal trend, with calculation of the annual percentage variation. A total of 6,503,941 requests for mammography and 6,002,916 for cytopathological examination were identified. The year 2020 had the lowest coverage in the entire time series. A consistent trend of increasing coverage of exams was observed in all regions of Brazil. Regarding cytopathology, the North region showed the highest proportional growth (25.6%), while the Central-West region showed the lowest annual percentage change (8.4%). Regarding mammography, the highest annual percentage change was recorded in the North region (19.2%), while the South region showed the lowest rate (10.3%), despite maintaining the highest absolute rates. Women's longevity perspective should be supported by health promotion strategies and early detection of pathologies that directly impact their quality of life, such as cancer.
- 2 October 2025
- Published by Portal de Periódicos UFU - Universidade Federal de Uberlandia in Hygeia - Revista Brasileira de Geografia Médica e da Saúde
- Vol. 21, e2161
Open AccessRASTREAMENTO DOS CÂNCERES DE MAMA E COLO DE ÚTERO EM MULHERES IDOSAS: ESTUDO DE SÉRIES TEMPORAIS
The study aims to analyze the temporal evolution of breast and cervical cancer screening coverage in elderly women in Brazil. This is an ecological time-series study, between 2014 and 2022, in Brazilian women aged ≥ 60 years. Adherence to screening was assessed by accessing the requests available in the Cancer Information System. The temporal evolution analyses were performed by dividing the number of requests among women aged over 60 years by the female population in the same age group, multiplying the result by one thousand for each year of the series. The Prais-Winsten linear regression model was applied to analyze the temporal trend, with calculation of the annual percentage variation. A total of 6,503,941 requests for mammography and 6,002,916 for cytopathological examination were identified. The year 2020 had the lowest coverage in the entire time series. A consistent trend of increasing coverage of exams was observed in all regions of Brazil. Regarding cytopathology, the North region showed the highest proportional growth (25.6%), while the Central-West region showed the lowest annual percentage change (8.4%). Regarding mammography, the highest annual percentage change was recorded in the North region (19.2%), while the South region showed the lowest rate (10.3%), despite maintaining the highest absolute rates. Women's longevity perspective should be supported by health promotion strategies and early detection of pathologies that directly impact their quality of life, such as cancer.
- Open Access
- 3 September 2025
- Published by Universidade Paranaense in Arquivos de Ciências da Saúde da UNIPAR
- Vol. 29 (3) , 1588-1606
ARANEÍSMO NA AMÉRICA DO SUL
Os casos de acidentes por aranhas são conhecidos como araneísmo, resultam da inoculação de toxinas por meio das quelíceras. De acordo com o Ministério da Saúde do Brasil, três gêneros se destacam pela importância médica: Phoneutria, Loxosceles e Latrodectus. Apresentar as principais evidências científicas disponíveis sobre o araneísmo na América do Sul. Para isso, foi realizada uma revisão bibliográfica nas bases de dados Portal de Periódicos da CAPES, Lilacs e Medline nos anos de 2000 a 2023. As produções incluídas mostraram um aumento nas publicações sobre o tema, com uma concentração em loxoscelismo, seguido por foneutrismo e latrodectismo em menor quantidade. A literatura aponta uma busca pela qualificação do tratamento dos acidentes causados por aranhas, quanto a necessidade de se conhecer melhor a Biologia e a Ecologia destes animais, além da importância de qualificar as notificações.
- 3 September 2025
- Published by Universidade Paranaense in Arquivos de Ciências da Saúde da UNIPAR
- Vol. 29 (3) , 1588-1606
Open AccessARANEÍSMO NA AMÉRICA DO SUL
Os casos de acidentes por aranhas são conhecidos como araneísmo, resultam da inoculação de toxinas por meio das quelíceras. De acordo com o Ministério da Saúde do Brasil, três gêneros se destacam pela importância médica: Phoneutria, Loxosceles e Latrodectus. Apresentar as principais evidências científicas disponíveis sobre o araneísmo na América do Sul. Para isso, foi realizada uma revisão bibliográfica nas bases de dados Portal de Periódicos da CAPES, Lilacs e Medline nos anos de 2000 a 2023. As produções incluídas mostraram um aumento nas publicações sobre o tema, com uma concentração em loxoscelismo, seguido por foneutrismo e latrodectismo em menor quantidade. A literatura aponta uma busca pela qualificação do tratamento dos acidentes causados por aranhas, quanto a necessidade de se conhecer melhor a Biologia e a Ecologia destes animais, além da importância de qualificar as notificações.
- Open Access
- 26 June 2025
- Published by Sciencedomain International in Archives of Current Research International
- Vol. 25 (7) , 638-647
Covid-19 Epidemiology in the Southern Brazilian States from 2020 to 2024
Aims: analyze the epidemiology of Covid-19 in southern Brazil from 2020 to 2024 Study Design: this is an epidemiological, descriptive and cross-sectional study. Place and Duration of Study: Brazil. held from April to June 2024. Methodology: data from the IT Department of the Unified Health System were utilized. The Kruskal–Wallis test was employed to compare and analyze the incidence, mortality, and lethality of COVID-19 across the states and municipalities of southern Brazil. The associations between variables were assessed using the Chi-square test in the Past software. Spatial distribution maps of incidence and mortality in the region were generated using MATLAB. Results: Paraná recorded the highest mortality rate (410,1 per 100.000 inhabitants) and lethality rate (1,6%) among the three states. However, the Paraná region had the lowest incidence of cases (26.367,3 per 100.000 inhabitants). Rio Grande do Sul had an incidence of 28.886,6 per 100.000 inhabitants, a mortality rate of 374,4 per 100.000 inhabitants, and a lethality rate of 1.4%. Finally, Santa Catarina had an incidence of 27.353,8 per 100.000 inhabitants and the lowest mortality (303,5 per 100.000) and lethality (1,1%) rates compared to the other regions. Cases and deaths were more concentrated in regions bordering Argentina and Paraguay, as well as along the borders with the states of Mato Grosso do Sul and São Paulo, in addition to the coastal areas. In 2022, the highest incidence was recorded across all states in the region, while the highest lethality and mortality rates occurred in 2021. Conclusion: the mortality and lethality rates of COVID-19 were not homogeneous among the states in the southern region. The distribution of mortality and lethality in the region for each year evaluated may be attributed to the stage of population immunization and the predominant variant. These data are important for guiding public health policies in the management of future pandemics.
- 26 June 2025
- Published by Sciencedomain International in Archives of Current Research International
- Vol. 25 (7) , 638-647
Open AccessCovid-19 Epidemiology in the Southern Brazilian States from 2020 to 2024
Aims: analyze the epidemiology of Covid-19 in southern Brazil from 2020 to 2024 Study Design: this is an epidemiological, descriptive and cross-sectional study. Place and Duration of Study: Brazil. held from April to June 2024. Methodology: data from the IT Department of the Unified Health System were utilized. The Kruskal–Wallis test was employed to compare and analyze the incidence, mortality, and lethality of COVID-19 across the states and municipalities of southern Brazil. The associations between variables were assessed using the Chi-square test in the Past software. Spatial distribution maps of incidence and mortality in the region were generated using MATLAB. Results: Paraná recorded the highest mortality rate (410,1 per 100.000 inhabitants) and lethality rate (1,6%) among the three states. However, the Paraná region had the lowest incidence of cases (26.367,3 per 100.000 inhabitants). Rio Grande do Sul had an incidence of 28.886,6 per 100.000 inhabitants, a mortality rate of 374,4 per 100.000 inhabitants, and a lethality rate of 1.4%. Finally, Santa Catarina had an incidence of 27.353,8 per 100.000 inhabitants and the lowest mortality (303,5 per 100.000) and lethality (1,1%) rates compared to the other regions. Cases and deaths were more concentrated in regions bordering Argentina and Paraguay, as well as along the borders with the states of Mato Grosso do Sul and São Paulo, in addition to the coastal areas. In 2022, the highest incidence was recorded across all states in the region, while the highest lethality and mortality rates occurred in 2021. Conclusion: the mortality and lethality rates of COVID-19 were not homogeneous among the states in the southern region. The distribution of mortality and lethality in the region for each year evaluated may be attributed to the stage of population immunization and the predominant variant. These data are important for guiding public health policies in the management of future pandemics.
- 25 April 2025
- Published by Springer Nature in Journal of the Brazilian Society of Mechanical Sciences and Engineering
- Vol. 47 (6) , 1-15
The lower shear modulus of younger subjects can result in stronger Achilles tendons: an in silico analysis
- 25 April 2025
- Published by Springer Nature in Journal of the Brazilian Society of Mechanical Sciences and Engineering
- Vol. 47 (6) , 1-15
The lower shear modulus of younger subjects can result in stronger Achilles tendons: an in silico analysis